| 发明名称 |
Vaccine composition comprising an immunoadjuvant compound consisting of a Rho GTPase family activator |
| 摘要 |
This invention is based on the experimental finding that activators of Rho GTPases, namely the cytotoxic necrotizing factor 1 (CNF1), and DNT bear immunostimulatory properties towards the systemic response to orally administered ovalbumine. This invention concerns a vaccine composition including an immunoadjuvant compound, wherein the immunoadjuvant compound consists of a Rho GTPase activator.
|
| 申请公布号 |
US7655240(B2) |
申请公布日期 |
2010.02.02 |
| 申请号 |
US20050589505 |
申请日期 |
2005.02.25 |
| 申请人 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
发明人 |
LEMICHEZ EMMANUEL;CZERKINSKY CECIL;ANJUERE FABIENNE;BOQUET PATRICE;MUNRO PATRICK;FLATAU GILLES |
| 分类号 |
A61K39/02;A61K39/39 |
主分类号 |
A61K39/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
